Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.4602 per EA under NDC 64380071003. Its NADAC has been published 386 times since Sep 12, 2018.
Strength
150 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380071003
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA090457On Market Since
10/19/2018
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 386 times since Sep 12, 2018, and over the history we have for it it has declined 56.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4602 per EA |
|---|---|
| All-time high | $1.2884 (Jan 16, 2019) |
| All-time low | $0.4126 (Oct 22, 2025) |
| 52-week high | $0.5088 |
| 52-week low | $0.4126 |
| Median price | $0.8475 |
| Average price | $0.8088 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 386 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Strides Pharma Inc., is $0.4602 per EA (NDC 64380071003), effective Jun 24, 2026.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 56.3%. It has been tracked across 386 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since Sep 12, 2018, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4126 (Oct 22, 2025) to a high of $1.2884 (Jan 16, 2019), with a median of $0.8475 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as LAMIVUDINE 150 MG TABLET, but none are currently priced below it.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 64380071003) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification